Pain Patch OEM FDA Facility Registration Step-by-Step Guide: 2026 B2B Compliance Walkthrough

Author:Kangdi 30-07-2026

Audience: Importers, distributors, brand owners, and regulatory affairs professionals sourcing pain patches from China OEM manufacturers.

Reading time: 12 minutes

What you'll get: The 7-step FDA Facility Registration process for cosmetic and OTC positioned pain patches, the 4 documentation requirements, annual renewal timeline, and 5 common pitfalls that delay sourcing by 60-90 days.

1. Why Facility Registration Matters

FDA Facility Registration is the single most common compliance step that catches first-time China pain patch buyers off guard. Every factory that ships any drug, cosmetic, or medical device product to the United States — even if the product is positioned as cosmetic — must register with FDA. The process is straightforward in principle (7 steps, 4 documents), but each step has a timing trap that delays sourcing projects by 60-90 days if missed.

The legal basis: Section 510 of the Federal Food, Drug, and Cosmetic Act requires all establishments that manufacture, prepare, propagate, compound, or process drugs (including OTC) or cosmetics to register with FDA. Failure to register results in the products being "refused admission" at US customs — meaning they cannot be sold, and may even be destroyed.

Who must register: Any facility (domestic or foreign) that:

• Manufactures or processes a drug product (including OTC monograph products) shipped to the US
• Manufactures or processes a cosmetic product shipped to the US (since 2023, under MoCRA)
• Acts as a contract manufacturer for any of the above

When to register: New establishments must register within 5 days of beginning operations. Foreign establishments must register before shipping any product to the US.

2. The 7-Step Facility Registration Process

Step 1 — Determine the Facility Type

The first decision is whether your pain patch factory needs to register as a drug facility, cosmetic facility, or both.

• Drug facility registration: Required if any pain patch product is positioned as OTC monograph (e.g., capsaicin >0.1%, lidocaine 4-5%, menthol >16% in a topical analgesic monograph claim).
• Cosmetic facility registration: Required if any pain patch product is positioned as cosmetic (capsaicin ≤0.1%, lidocaine ≤1%, menthol in cosmetic positioning).
• Both: Many factories register for both, since they may ship different SKUs to different markets with different positioning.

The registration type determines the form you use (Step 2) and the documentation you submit (Step 4).

Step 2 — Create a Unified Listing Account

FDA uses the Unified Listing platform for both drug and cosmetic facility registration. If the factory does not already have a Unified Listing account:

1. Go to https://www.accessdata.fda.gov/scripts/oombu/
2. Select "Create Account" for the appropriate type (drug, cosmetic, or both)
3. Provide establishment name, address, contact information
4. Set up account security questions and password

The account is per-establishment, not per-product. If the factory has multiple production facilities, each must register separately.

Step 3 — Pay the Registration Fee

Drug Facility Registration has an annual fee. For fiscal year 2026, the fee is approximately $5,672 per facility. Cosmetic facility registration under MoCRA has a separate fee structure (the cosmetic facility registration was new in 2023).

Foreign establishments pay the same fee as domestic ones. The fee must be paid before the registration form can be submitted. Payment is by credit card or wire transfer through the FDA payment portal.

If the factory refuses to pay this fee or asks the buyer to cover it, that is a red flag — the fee is a normal cost of doing business in the US market and is typically $1-2 per patch at scale.

Step 4 — Submit the Registration Form

The form requires 4 categories of information:

4.1 Establishment information

• Legal name and address (must match the physical production facility)
• Trade name (DBA) if different
• DUNS number or FEI number (FDA Establishment Identifier)
• Contact information (name, email, phone)
• Emergency contact (24-hour availability)

4.2 Product information

• For drug facilities: list all drug products manufactured at this facility (brand name, dosage form, active ingredient, NDC if assigned)
• For cosmetic facilities: list all cosmetic products manufactured at this facility (product name, category, ingredient declaration summary)

4.3 Manufacturing information

• Type of operations performed (manufacturing, packaging, labeling, testing)
• Production lines and capacities (for cosmetic facilities under MoCRA)
• Quality system certification (ISO 13485, 21 CFR 210/211 GMP, ISO 22716)

4.4 Importer information (for foreign facilities only)

• US Agent name and contact (required for all foreign facilities)
• US Agent must be a US resident or US-located business
• US Agent serves as the FDA's local point of contact

Step 5 — Designate a US Agent

Every foreign facility must designate a US Agent. The US Agent is a person or business physically located in the United States who serves as FDA's communication channel for that facility.

The US Agent does NOT need to be the importer. Common options:

• The buyer's US entity (if the buyer has a US subsidiary)
• A US-based regulatory affairs consultant
• A customs broker with regulatory expertise
• A US distributor or sales agent

The US Agent's responsibilities include:

• Responding to FDA correspondence within 24-48 hours
• Forwarding FDA inquiries to the foreign facility
• Maintaining accurate contact information in the FDA database

If the US Agent changes, the foreign facility must update the registration within 30 days.

Step 6 — Receive FDA Confirmation

After submission, FDA typically processes the registration within 1-3 business days. The facility will receive:

1. A confirmation email from FDA
2. A Facility Registration Number (10 digits, format: 3xxxxxxxxx)
3. An FEI number if the facility does not already have one
4. Access to the FDA Establishment Registration database for verification

The Facility Registration Number must appear on:

• All shipping documents (commercial invoice, packing list)
• The US Customs entry filing (via the importer of record)
• Product labeling for drug products (as the establishment of manufacture)

For cosmetic products, the Facility Registration Number is not required on labeling, but the facility must still be registered.

Step 7 — Maintain the Registration Annually

Facility Registration is renewed annually. The renewal window is October 1 to December 31 of each year for the following fiscal year. Foreign facilities that miss the renewal window lose their registration and must re-register from scratch.

Annual renewal tasks:

1. Log in to the Unified Listing account between October 1 and December 31
2. Verify all establishment information is current (address, US Agent, contact info)
3. Update product list (add new SKUs, remove discontinued SKUs)
4. Pay the annual registration fee
5. Receive renewed confirmation and updated Facility Registration Number

Many Chinese OEM factories handle the renewal themselves. Some rely on US importers or regulatory consultants. The renewal is the buyer's responsibility to verify before placing the first PO of each calendar year.

3. The 5 Common Pitfalls

Pitfall 1 — Failing to register before first shipment. This is the most common mistake. The factory has the registration but has not renewed it for 2+ years, or has never registered. Products arrive at US customs and are refused admission. Loss: 60-90 days of shipping delay + storage costs.

Pitfall 2 — Wrong facility address on the registration. The address on the registration must match the physical production facility. If the factory operates from multiple locations (production, warehouse, office), each production site must register separately.

Pitfall 3 — Missing US Agent or unresponsive US Agent. FDA requires a US Agent for foreign facilities. If the US Agent moves, retires, or becomes unresponsive, the registration is effectively non-functional. Update US Agent within 30 days of any change.

Pitfall 4 — Cosmetic-only registration for OTC-positioned products. If the factory only has cosmetic Facility Registration but ships products with OTC monograph claims, FDA will treat it as a drug facility compliance failure. Verify the registration type matches the product positioning.

Pitfall 5 — Missing the October-December renewal window. Facility Registration lapses if not renewed annually between October 1 and December 31. Many Chinese factories forget this. Verify renewal before placing POs in January-April of any year.

4. Facility Registration vs. Facility Registration vs. Drug Master File

These three terms are often confused. Here is the distinction:

A factory shipping only cosmetic-positioned patches needs only Facility Registration. A factory shipping OTC-positioned patches needs Facility Registration + Facility Registration + (per API) DMF or CEP. For more on the documentation tiers, see Pain Patch OEM Compliance Documentation Checklist 2026.

5. The Buyer Verification Checklist

Before placing the first PO, the buyer should verify 5 facts about the factory's Facility Registration:

1. Active status — verify in the FDA Establishment Registration database at https://www.accessdata.fda.gov/scripts/oombu/ (search by name or FEI number)
2. Current renewal year — confirm the registration is current for the year of shipment
3. Correct facility type — drug facility, cosmetic facility, or both (matches the product positioning)
4. US Agent listed and reachable — verify the US Agent contact responds to a test email within 48 hours
5. Product list includes your SKU — verify your specific pain patch SKU is in the product list (especially for OTC positioning)

A 30-minute verification saves 60-90 days of customs delay.

6. FAQ (5 Questions)

FAQ 1: Does the buyer or the factory pay the Facility Registration fee?

The factory pays. The annual fee ($5,672 for FY2026 drug facility) is a normal cost of doing business in the US market. The buyer can verify the fee has been paid by checking the FDA database, but should not pay the fee directly unless the buyer also operates a US facility that needs to register. If a factory asks the buyer to cover the registration fee as a condition of business, treat it as a red flag.

FAQ 2: How do I verify a Facility Registration is real?

Go to the FDA Establishment Registration database at https://www.accessdata.fda.gov/scripts/oombu/. Search by establishment name, FEI number, or registration number. The database is updated daily. A legitimate factory will provide the FEI number proactively and respond to verification requests within 24 hours.

FAQ 3: Can one Facility Registration cover multiple product SKUs?

Yes — one Facility Registration covers all products manufactured at that facility. The product list in the registration can include dozens or hundreds of SKUs. There is no fee per SKU; the fee is per facility.

FAQ 4: What happens if a product ships before Facility Registration is current?

The product is "refused admission" at US customs. The buyer has three options:

1. Return the shipment to the factory (most expensive)
2. Hold the shipment in a US bonded warehouse and register within 30 days (less expensive but still costly)
3. Destroy the shipment (cheapest if the product cannot be sold legally)

Any of these options is significantly more expensive than ensuring the registration is current before shipment.

FAQ 5: Is Facility Registration the same as ISO 13485 certification?

No. Facility Registration is a US FDA legal requirement; ISO 13485 is an international QMS standard. They are independent and complementary. A factory can have one without the other. For US OTC positioning, Facility Registration is mandatory and ISO 13485 is recommended. For cosmetic positioning, Facility Registration is mandatory and ISO 22716 cosmetic GMP is recommended.

7. Conclusion

Facility Registration is the gateway to the US market for pain patches — and the most common source of customs delays for first-time China OEM buyers. Use the 7-step process above to verify the factory's registration status before placing the first PO. Verify the registration is current, the facility type matches the product positioning, the US Agent is reachable, and your specific SKU is in the product list.

For the broader 28-document compliance checklist, see Pain Patch OEM Compliance Documentation Checklist 2026. For the factory qualification framework, see Pain Patch OEM Factory Audit 2026 Part 1.

If you would like to discuss Facility Registration for your specific pain patch OEM project, including the US Agent designation and the annual renewal workflow, contact Henan Kangdi Medical Devices at kangdimedical@gmail.com or +86 155 1754 1011. We have produced pain patches since 1989 and maintain active Facility Registration for both drug and cosmetic positioning.

References

1. FDA — Facility Registration (Drug): https://www.accessdata.fda.gov/scripts/oombu/
2. FDA — Drug Master Files (DMF): https://www.fda.gov/drugs/forms-submission-requirements/drug-master-files-dmfs
3. FDA — MoCRA Cosmetic Product Facility Registration: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2023-mocra
4. FDA — Federal Food, Drug, and Cosmetic Act Section 510: https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act
5. FDA — US Agent guidance for foreign facilities: https://www.fda.gov/industry/fda-basics-industry/us-agents
6. FDA — Facility Registration Fee schedule: https://www.fda.gov/industry/fda-user-fee-programs
7. FDA — Cosmetic Product Listing: https://www.fda.gov/cosmetics/registration-listing-cosmetic-products/cosmetic-product-listing
8. EDQM — CEP (Certificate of Suitability): https://www.edqm.eu/en/cep-application-procedure
9. ISO 13485:2016 — Medical devices QMS: https://www.iso.org/standard/59752.html
10. ISO 22716:2007 — Cosmetic GMP: https://www.iso.org/standard/36494.html
11. 21 CFR 207 — Registration of producers of drugs: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-207
12. 21 CFR 210/211 — GMP for pharmaceutical products: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-210
13. EyouCMS robots.txt optimization — Facility Registration compliance: kangdimedical.com/robots.txt
14. PIC/S GMP Guide (PE 009-15): https://picscheme.org/en/publications

Contact: For OEM/ODM inquiries, email kangdimedical@gmail.com or call +86 155 1754 1011.Updated: July 2026. Information current as of publication date. FDA registration requirements and fees change annually. Always verify with the FDA Establishment Registration database before placing orders.